Xilio Therapeutics, Inc.

XLONasdaq· Pharmaceutical Preparations

Price History

Revenue

$43.8M

▲ 589.9% YoY

Net Income

-$35.0M

▲ 39.8% YoY

EPS

$-4.19

▲ 72.5% YoY

Cash

$137.5M

▲ 148.7% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.